An Emerging Option to Treat DME

Anti-VEGF Debate: Are Intravitreal Agents AssociatedWith Elevated IOP?

ARVO 2013: Highlights From Eight Key Studies

Anti-VEGF under-treatment among surprising findings.

By Jerry Helzner, contributing editor

Calendar

Coding

Coding for Multi-surgeon Cases: Part 1

Controversies in Care

Primary Treatment of Di use DME in Pseudophakic Individuals: Anti-inflammatory or Anti-VEGF?

CT Spotlight

An Antibiotic for Dry AMD?

CT Update

Early Vitrectomy for DME: What Makes It a Viable Treatment?

Focus On

Argus II Improves Sight in RP

By Stuart Michaelson, Contributing

Integrating Image Management Into EHR Systems

Journal Club

Micropulse Laser Therapy For the Treatment of DME

Multimodal Imaging In Acute Macular Neuroretinopathy

Subspecialty News

Allergan sees delay in DARPin program; Regeneron plans new clinical trials; Same-day, next-day RD surgery; and more

By Jerry Helzner, contributing editor

Update on Portable Vitrector Technology and Applications

Upfront

Who Will Be the Next ‘Great One’?

Vitrectomy for DME Without Macular Traction

Roundtable Participants

VersaVIT for Vitrectomy